Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
Provided By GlobeNewswire
Last update: Sep 15, 2025
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
IRVINE, CA, and HERSTAL, BELGIUM – September 15, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the closing of the ExoDx business acquisition from Bio-Techne Corporation, which includes the ExoDx Prostate test.
Read more at globenewswire.com
